Vijaya Diagnostic Centre Limited
Vijaya Diagnostic Centre Limited (VIJAYA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
vijayadiagnostic.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 Cr | 133 Cr | 155 Cr | 156 Cr | 183 Cr | 169 Cr | 173 Cr | 188 Cr | 202 Cr | 205 Cr | 219 Cr | 231 Cr |
| Operating expenses (approx.) | 81 Cr | 80 Cr | 92 Cr | 95 Cr | 107 Cr | 102 Cr | 104 Cr | 115 Cr | 120 Cr | 119 Cr | 124 Cr | 132 Cr |
| EBITDA | 57 Cr | 52 Cr | 63 Cr | 61 Cr | 76 Cr | 67 Cr | 69 Cr | 74 Cr | 82 Cr | 86 Cr | 96 Cr | 99 Cr |
| OPM % | 41.3% | 39.4% | 40.7% | 39.2% | 41.5% | 39.7% | 39.8% | 39.1% | 40.6% | 41.9% | 43.5% | 42.7% |
| Other income | 7 Cr | 5 Cr | 3 Cr | 4 Cr | 5 Cr | 5 Cr | 6 Cr | 7 Cr | 6 Cr | 5 Cr | 2 Cr | 9 Cr |
| Interest | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 7 Cr | 7 Cr | 7 Cr | 8 Cr | 9 Cr | 9 Cr | 11 Cr |
| Depreciation | 14 Cr | 15 Cr | 16 Cr | 17 Cr | 17 Cr | 18 Cr | 19 Cr | 21 Cr | 22 Cr | 24 Cr | 24 Cr | 25 Cr |
| Profit before tax | 45 Cr | 35 Cr | 44 Cr | 42 Cr | 57 Cr | 47 Cr | 47 Cr | 52 Cr | 58 Cr | 58 Cr | 64 Cr | 71 Cr |
| Tax % | 24.7% | 25.2% | 23.2% | 24.8% | 26.3% | 24.4% | 26.4% | 26.1% | 25.4% | 25.8% | 25.4% | 25.2% |
| Net profit | 34 Cr | 26 Cr | 34 Cr | 32 Cr | 42 Cr | 35 Cr | 35 Cr | 39 Cr | 43 Cr | 43 Cr | 48 Cr | 53 Cr |
| EPS (₹) | ₹3.26 | ₹2.53 | ₹3.27 | ₹3.06 | ₹4.09 | ₹3.42 | ₹3.38 | ₹3.76 | ₹4.21 | ₹4.20 | ₹4.66 | ₹5.16 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 462 Cr | 459 Cr | 548 Cr | 681 Cr | 814 Cr | Sign in for TTM |
| Operating expenses (approx.) | 259 Cr | 277 Cr | 327 Cr | 408 Cr | 477 Cr | Sign in for TTM |
| EBITDA | 204 Cr | 182 Cr | 221 Cr | 273 Cr | 337 Cr | Sign in for TTM |
| OPM % | 44.1% | 39.6% | 40.3% | 40.1% | 41.4% | Sign in for TTM |
| Other income | 13 Cr | 14 Cr | 21 Cr | 18 Cr | 21 Cr | Sign in for TTM |
| Interest | 16 Cr | 21 Cr | 24 Cr | 27 Cr | 33 Cr | Sign in for TTM |
| Depreciation | 53 Cr | 62 Cr | 57 Cr | 71 Cr | 92 Cr | Sign in for TTM |
| Profit before tax | 147 Cr | 114 Cr | 159 Cr | 193 Cr | 233 Cr | Sign in for TTM |
| Tax % | 24.9% | 24.9% | 24.6% | 25.6% | 25.7% | Sign in for TTM |
| Net profit | 111 Cr | 85 Cr | 120 Cr | 144 Cr | 173 Cr | Sign in for TTM |
| EPS (₹) | ₹10.76 | ₹8.29 | ₹11.62 | ₹13.95 | ₹16.81 | Sign in for TTM |
| Dividend payout % | 0.0% | 12.0% | 8.5% | 7.1% | 11.9% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr |
| Reserves | 458 Cr | 535 Cr | 647 Cr | 785 Cr | 947 Cr |
| Borrowings | 0.63 Cr | — | — | — | — |
| Other liabilities | 243 Cr | 307 Cr | 323 Cr | 474 Cr | 550 Cr |
| Total liabilities | 713 Cr | 853 Cr | 983 Cr | 1,274 Cr | 1,507 Cr |
| Fixed assets (net) | 364 Cr | 294 Cr | 602 Cr | 724 Cr | 930 Cr |
| CWIP | 34 Cr | 249 Cr | 8 Cr | 70 Cr | 34 Cr |
| Investments | 54 Cr | 139 Cr | 109 Cr | 185 Cr | 228 Cr |
| Inventories | 4 Cr | 2 Cr | 5 Cr | 5 Cr | 5 Cr |
| Trade receivables | 10 Cr | 9 Cr | 16 Cr | 15 Cr | 21 Cr |
| Cash & bank | 11 Cr | 24 Cr | 22 Cr | 13 Cr | 40 Cr |
| Other assets | 236 Cr | 135 Cr | 220 Cr | 263 Cr | 249 Cr |
| Total assets | 713 Cr | 853 Cr | 983 Cr | 1,274 Cr | 1,507 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 158 Cr | 165 Cr | 183 Cr | 224 Cr | 271 Cr |
| Cash from investing | -123 Cr | -110 Cr | -142 Cr | -182 Cr | -174 Cr |
| Cash from financing | -31 Cr | -42 Cr | -45 Cr | -52 Cr | -69 Cr |
| Net cash flow | 4 Cr | 13 Cr | -4 Cr | -9 Cr | 27 Cr |
| Free cash flow (OCF − Capex) | 36 Cr | 40 Cr | 95 Cr | 129 Cr | 88 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 34.8% | 24.6% | 27.7% | 27.5% | 27.8% |
| ROE % | 26.3% | 15.5% | 18.0% | 17.9% | 18.1% |
| Debtor days | 8 | 8 | 11 | 8 | 9 |
| Inventory days | 22 | 13 | 29 | 21 | 19 |
| Days payable | 110 | 171 | 184 | 142 | 144 |
| Cash conversion cycle | -81 | -151 | -144 | -113 | -116 |
| Debt / equity | 0.0014 | — | — | 0.00 | 0.00 |
| Current ratio | 4.08 | 4.17 | 2.90 | 1.89 | 2.60 |
| Net debt / EBITDA | 0.00 | -0.13 | -0.10 | -0.05 | -0.12 |
Compare with peers
Loading peers…